Evidence map›Paper›PMID 37755197›Full record

ArticleMembranes2023

Acrylonitrile-Acrylic Acid Copolymer Ultrafiltration Membranes for Selective Asphaltene Removal from Crude Oil.

Alexey A Yushkin, Alexey V Balynin, Alexandra P Nebesskaya, Elena V Chernikova, Dmitriy G Muratov, Mikhail N Efimov, Galina P Karpacheva

Open access · goldAbstract read
In one paragraph

Article in Membranes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Alexey A YushkinA.V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences, 29 Leninsky Prospekt, 119991 Moscow, Russia.ORCID 0000-0002-0118-1515
Alexey V BalyninA.V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences, 29 Leninsky Prospekt, 119991 Moscow, Russia.
Alexandra P NebesskayaA.V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences, 29 Leninsky Prospekt, 119991 Moscow, Russia.
Elena V ChernikovaA.V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences, 29 Leninsky Prospekt, 119991 Moscow, Russia.ORCID 0000-0002-0987-755X
Dmitriy G MuratovA.V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences, 29 Leninsky Prospekt, 119991 Moscow, Russia.
Mikhail N EfimovA.V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences, 29 Leninsky Prospekt, 119991 Moscow, Russia.ORCID 0000-0001-7996-474X
Galina P KarpachevaA.V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences, 29 Leninsky Prospekt, 119991 Moscow, Russia.ORCID 0000-0003-4582-8226
Russian Academy of Sciences · RU

Funding

Russian Science Foundation 18-79-10260
6 · The paper itself

Abstract

In this study, ultrafiltration membranes were developed via a nonsolvent-induced phase separation method for the removal of asphaltenes from crude oil. Polyacrylonitrile (PAN) and acrylonitrile copolymers with acrylic acid were used as membrane materials. Copolymerizing acrylonitrile with acrylic acid resulted in an improvement in the fouling resistance of the membranes. The addition of 10% of acrylic acid to the polymer chain decreases the water contact angle from 71° to 43°, reducing both the total fouling and irreversible fouling compared to membranes made from a PAN homopolymer. The obtained membranes with a pore size of 32-55 nm demonstrated a pure toluene permeance of 84.8-130.4 L/(m

Indexed as

asphaltenesmembraneoil fractionationpolyacrylonitrilepore sizeultrafiltration

Identifiers

PMID37755197
PMCPMC10538228
OpenAlexW4386378655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.